Reply To: Traders Market Weekly: Inflation and Bank Earnings

#50667
TradersCom
Keymaster

Wrecked: Phathom Pharmaceuticals $PHAT down 24.9%

FDA notified the company that no action will be taken on its NDA for vonoprazan;
Meaning Phathom no longer expects product launches for H. pylori or erosive esophagitis in 1Q23.